Published: May 21, 2021 By Alex Keown
Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.
AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Prior to bluebird bio, Hanrahan held positions of increasing responsibility at Genzyme Corp. where she worked across the oncology, multiple sclerosis and rare disease therapeutic areas. Earlier in her career, Hanrahan worked at Boston Scientific Corporation.
Janssen Receives Two Positive CHMP Opinions Recommending Expanded Use of DARZALEX? (daratumumab) Subcutaneous (SC) Formulation for New Indications in Europe finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
White House Blocks Discrimination Against LGBTQ Patients By Alicia Ault
May 11, 2021 The Biden administration is reversing a Trump-era policy that allowed health care providers to refuse to treat lesbian, gay, bisexual, transgender, or queer (LGBTQ) patients.
The Department of Health and Human Services gave notice Monday that it interprets the Affordable Care Act which bars discrimination on the basis of sex to include discrimination on the basis of sexual orientation or gender identity. The department said its position is consistent with a June Supreme Court ruling in
Bostock v. Clayton County, GA. The court ruled that the Civil Rights Act s prohibition of employment discrimination on the basis of sex includes sexual orientation and gender identity.